The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat.
1 The response of pentobarbitone-anaesthetized cats to the intravenous administration of E. coli endotoxin (2 mg/kg) consisted of acute pulmonary vasoconstriction (3-5 min after the injection) and a secondary shock phase characterized by delayed systemic hypotension, decreased central venous pressure and cardiac output, and metabolic acidosis with arterial lactate levels three to four times normal. Only one of 25 animals survived 6 hours.2 Indomethacin (10 mg/kg), administered intravenously 30 min before the endotoxin, reduced both systemic arterial pressure and myocardial blood flow. It abolished the pulmonary vasoconstriction induced by endotoxin.3 Indomethacin modified some of the characteristic features of the delayed, endotoxin shock phase. Systemic hypotension was not observed and the blood pressure in the indomethacintreated cats 1, 2 and 4 h after endotoxin was 30 mmHg higher than in those cats administered endotoxin alone. The decrease in arterial pH was also significantly delayed. Six out of 15 animals survived 6 hours.4 It is suggested that indomethacin may abolish the initial pulmonary hypertension and oedema by antagonizing the release, or vasoconstrictor effect, of histamine and that part of its action during the shock phase is due to inhibition of prostaglandin release.
D000138:Acidosis / Q000209:etiology*; D000818:Animals; D001158:Arteries; D001769:Blood; D001786:Blood Glucose; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D002496:Central Venous Pressure / Q000187:drug effects; D004731:Endotoxins / Q000494:pharmacology*; D004926:Escherichia coli; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D006976:Hypertension, Pulmonary / Q000517:prevention & control; D007022:Hypotension / Q000139:chemically induced; D007213:Indomethacin / Q000494:pharmacology*; D007275:Injections, Intravenous; D007773:Lactates / Q000097:blood; D008297:Male; D011652:Pulmonary Circulation / Q000187:drug effects; D011654:Pulmonary Edema / Q000517:prevention & control; D012772:Shock, Septic / Q000517:prevention & control*
D001786:Blood Glucose; D004731:Endotoxins; D007773:Lactates; D007213:Indomethacin